New Imaging Method Could Improve Asthma Treatment – Drug Discovery & Development


Drug Discovery & Development

New Imaging Method Could Improve Asthma Treatment
Drug Discovery & Development
A team of researchers, led by the Universities of Cambridge and Birmingham, have used a laser beam trap to examine how drug particles from asthma inhalers behave as they are projected through the air. Their findings could improve the effectiveness of …

and more »

View full post on asthma – Google News

Newly Developed Vaccines Could Reveal Asthma Clues – Drug Discovery & Development


Drug Discovery & Development

Newly Developed Vaccines Could Reveal Asthma Clues
Drug Discovery & Development
Their potential application to disorders such as asthma has a somewhat different focus. Macrophages that are able to sustain their activation state for prolonged periods might also contribute to chronic lung diseases such as asthma and COPD
Developing Lifesaving Vaccines in a New WayNewswise (press release)

all 2 news articles »

View full post on asthma – Google News

GSK Submits European, US Filings for Asthma Med – Drug Discovery & Development

GSK Submits European, US Filings for Asthma Med
Drug Discovery & Development
GlaxoSmithKline announced that it has filed regulatory submissions in the USA and Europe for mepolizumab for approval as a maintenance treatment for patients with severe eosinophilic asthma, identified by a blood eosinophil count of at least 150 cells
GSK Files for Approval of Mepolizumab in US, Europe for Eosinophilic AsthmaRTT News
GSK submits asthma biologic in US, EUPharmaTimes
GlaxoSmithKline heads to the FDA with its next big respiratory betFierceBiotech
The Pharma Letter –London South East
all 8 news articles »

View full post on asthma – Google News

AstraZeneca Gets Positive Results for Asthma Drug – Drug Discovery & Development

AstraZeneca Gets Positive Results for Asthma Drug
Drug Discovery & Development
AstraZeneca announced that The Lancet Respiratory Medicine has published positive safety and efficacy data from a Phase 2b study evaluating benralizumab, a novel investigational monoclonal antibody, in patients with severe, uncontrolled asthma and …
AstraZeneca gets some upbeat asthma data to back would-be IL-5 blockbusterFierceBiotech
AstraZeneca share price: Novel drug shows positive results for severe asthmaiNVEZZ
AstraZeneca's benralizumab succeeds in severe asthmaPharmaTimes

all 5 news articles »

View full post on asthma – Google News

Influence of farming exposure on the development of asthma and asthma-like symptoms.

Related Articles

Influence of farming exposure on the development of asthma and asthma-like symptoms.

Int Immunopharmacol. 2014 Jul 30;

Authors: Wells AD, Poole JA, Romberger DJ

Abstract
Based upon age and type of farming exposures, a wide range of studies demonstrate either protective or deleterious effects of the farming environment on asthma. In this review, we highlight key studies supporting the concept that farming exposure protects children from asthma and atopy based on studies performed largely in European pediatric cohorts. Various types of farming in certain regions appear to have a greater effect on asthma protection, as does the consumption of unpasteurized milk. In the United State, where concentrated animal feeding operations (CAFOs) are more common, asthma is increased in children exposed especially to swine CAFOs; whereas, rates of atopy and allergy are lower in these children. We also review studies evaluating the role of farming exposures both as a child and/or as an adult on asthma seen in adults. The importance of microbes in farming environments and the contribution of various components of the innate immune system including toll-like receptors to the underlying mechanisms of asthma related to farming exposures are also reviewed.

PMID: 25086344 [PubMed – as supplied by publisher]

View full post on pubmed: asthma

Asmacure Posts Promising Phase 1/2a Asthma Drug Results – Drug Discovery & Development


Drug Discovery & Development

Asmacure Posts Promising Phase 1/2a Asthma Drug Results
Drug Discovery & Development
"The pharmacokinetics data from this study provided important information on the potential dose range for ASM-024 in the treatment of the moderate asthma patient when delivered as a dry powder for inhalation." ASM-024 is under development in a dry …

View full post on asthma – Google News

Type I interferons can block development of allergy- and asthma-driving Th2 cells – News-Medical.net

Type I interferons can block development of allergy- and asthma-driving Th2 cells
News-Medical.net
A mechanism that could underlie the development of cells that drive asthma and allergies has been uncovered by immunology researchers at UT-Southwestern Medical Center. Asthma and allergies are both driven by an inappropriate activation of the …

View full post on asthma – Google News